Current therapy for cutaneous melanoma

1969 Cancer Facts and Figures

1968 • 8,880 citations

Cancer: Principles and Practice of Oncology.

1991 • 8,402 citations

Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma

1992 • 4,391 citations

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

1987 • 2,769 citations

Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma

1970 • 2,415 citations

Cancer: Principles and Practice of Oncology

1994 • 1,825 citations

Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction

1990 • 1,307 citations

Model Predicting Survival in Stage I Melanoma Based on Tumor Progression

1989 • 1,235 citations

Treatment of 283 Consecutive Patients With Metastatic Melanoma or Renal Cell Cancer Using High-Dose Bolus Interleukin 2

1994 • 1,070 citations

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.

1993 • 888 citations

Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines

1994 • 841 citations

The ABCD rule of dermatoscopy

1994 • 835 citations

Important Advances in Oncology

1991 • 768 citations

Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer

1993 • 639 citations

A Multifactorial Analysis of Melanoma

1978 • 575 citations

Diagnosis and Treatment of Early Melanoma

1992 • 540 citations

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

1994 • 522 citations

Efficacy of 2-cm Surgical Margins for Intermediate-Thickness Melanomas (1 to 4 mm) Results of a Multi-institutional Randomized Surgical Trial

1993 • 518 citations

Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities

1982 • 505 citations

Narrow Excision (1-cm Margin)

1991 • 490 citations

High Risk of Malignant Melanoma in Melanoma-Prone Families with Dysplastic Nevi

1985 • 458 citations

Lymphadenectomy in the Management of Stage I Malignant Melanoma: A Prospective Randomized Study

1986 • 402 citations

Cutaneous Melanoma

1991 • 397 citations

Tumor thickness as a guide to surgical management of clinical stage I melanoma patients

1979 • 366 citations

A Comparison of Prognostic Factors and Surgical Results in 1,786 Patients with Localized (Stage I) Melanoma Treated in Alabama, USA, and New South Wales, Australia

1982 • 354 citations

In Vivo Epiluminescence Microscopy: Improvement of Early Diagnosis of Melanoma

1993 • 349 citations

NIH Consensus conference. Diagnosis and treatment of early melanoma

1992 • 320 citations

Risk Factors for Cutaneous Melanoma

1987 • 314 citations

Important advances in oncology 1994

1994 • 282 citations

Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck.

1993 • 277 citations

The regressing thin malignant melanoma. A distinctive lesion with metastatic potential

1978 • 271 citations

Sequential chemoimmunotherapy in the treatment of metastatic melanoma.

1992 • 258 citations

Patterns of Relapse in 1001 Consecutive Patients With Melanoma Nodal Metastases

1989 • 250 citations

Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA.

1993 • 243 citations

Treatment of Metastatic Malignant Melanoma with Dacarbazine plus Tamoxifen

1992 • 241 citations

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.

1988 • 239 citations

The role of elective lymph node dissection in melanoma: rationale, results, and controversies.

1988 • 238 citations

Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.

1984 • 234 citations

Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin

1991 • 227 citations

LYMPHOID MALIGNANCY

1974 • 211 citations

Head and Neck Melanoma in 534 Clinical Stage I Patients

1984 • 204 citations

Localization of111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response

1994 • 201 citations

Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma.

1991 • 200 citations

Lysis of Autologous Melanoma Cells by Tumor*Infiltrating Lymphocytes: Association With Clinical Response

1991 • 196 citations

Thin Malignant Melanomas With Regression and Metastases

1987 • 190 citations

Active-specific immunotherapy for melanoma.

1990 • 186 citations

Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and Metastasis

1982 • 186 citations

A phase II study of taxol in patients with malignant melanoma

1991 • 179 citations

Prognostic significance of the histological features of malignant melanoma

1979 • 175 citations

A phase II trial of taxol in metastatic melanoma

1990 • 175 citations

Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.

1993 • 165 citations

Factors Prognostic for Survival in Patients with Malignant Melanoma Spread to the Regional Lymph Nodes

1982 • 163 citations

Prognostic Factors in Patients Undergoing Lymphadenectomy of Malignant Melanoma

1977 • 163 citations

Stage I melanoma of the skin: Evaluation of prognosis according to histologic characteristics

1981 • 163 citations

Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.

1992 • 155 citations

Lentigo maligna melanoma has no better prognosis than other types of melanoma.

1984 • 155 citations

Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity?

1980 • 153 citations

Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma.

1994 • 153 citations

Clinical and Histopathologic Predictors of Survival in Patients With Malignant Melanoma: a Population-Based Study in Sweden

1994 • 152 citations

Optimal size of resection margin for thin cutaneous melanoma.

1977 • 151 citations

Statistical evaluation of epiluminescence microscopy criteria for melanocytic pigmented skin lesions

1993 • 148 citations

The Frequency of Local Recurrence and Microsatellites as a Guide to Reexcision Margins for Cutaneous Malignant Melanoma

1984 • 147 citations

Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanoma.

1993 • 147 citations

Prognosis in patients with thin malignant melanoma: influence of regression

1983 • 144 citations

Narrower Margins for Clinical Stage I Malignant Melanoma

1982 • 140 citations

“Microscopic satellites” are more highly associated with regional lymph node metastases than is primary melanoma thickness

1984 • 139 citations

Cutaneous melanoma and sunburns in childhood in a Southern European population

1992 • 136 citations

Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.

1991 • 135 citations

Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.

1990 • 133 citations

Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study

1991 • 131 citations

Antibodies as cytotoxic therapy.

1994 • 127 citations

Metastasectomy in malignant melanoma.

1994 • 123 citations

Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: results of a multi-institutional Australian randomized trial.

1993 • 121 citations

Does biopsy type influence survival in clinical Stage I cutaneous melanoma?

1985 • 120 citations

Melanoma and sun exposure: Contrasts between intermittent and chronic exposure

1992 • 119 citations

Prognostic factors in thin cutaneous malignant melanoma

1994 • 116 citations

Multiple primary cutaneous melanomas

1992 • 115 citations

Low- and high-risk malignant melanoma—I. Evaluation of clinical and histological prognosticators in 585 cases

1983 • 115 citations

A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma.

1992 • 114 citations

The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma

1989 • 114 citations

Dysplastic Nevi as Risk Markers of Sporadic (Nonfamilial) Melanoma

1991 • 113 citations

Biologic Behavior of Thin Malignant Melanomas With Regressive Changes

1983 • 111 citations

Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma.

1984 • 110 citations

Stage I melanoma of the skin: the problem of resection margins

1980 • 109 citations

Prognostic Significance of DNA Aneuploidy in Stage I Cutaneous Melanoma

1988 • 106 citations

Biopsy and Prognosis of Malignant Melanoma

1969 • 106 citations

Optimal Resection Margin for Cutaneous Malignant Melanoma

1983 • 105 citations

Thickness of Malignant Melanoma: Global Analysis of Related Factors

1987 • 104 citations

Malignant melanoma of the skin. I. The association of tumor depth and type, and patient sex, age, and site with survival

1983 • 100 citations

Optimal size of resection margin for thin cutaneous melanoma

1978 • 98 citations

Prognostic index for malignant melanoma

1987 • 97 citations

Therapy for cutaneous melanoma: An update

1990 • 97 citations

Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma.

1987 • 96 citations

Axillary Dissection in Melanoma

1990 • 91 citations

Prospective Follow‐Up for Malignant Melanoma in Patients with Atypical‐Mole (Dysplastic‐Nevus) Syndrome

1991 • 89 citations

Is actinic granuloma a specific condition?

1979 • 89 citations

Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.

1993 • 88 citations

Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.

1991 • 81 citations

A prognostic model for clinical stage I melanoma of the trunk

1981 • 80 citations

Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases

1985 • 80 citations

Fine needle aspiration biopsy of metastatic melanoma. A morphologic analysis of 174 cases.

1986 • 79 citations

Metastases of thin melanomas

1983 • 78 citations

A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.

1991 • 76 citations

Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases.

1991 • 76 citations

The role of surgery in the treatment of nonregionally recurrent melanoma.

1993 • 75 citations

Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk

1985 • 73 citations

The Queensland Melanoma Project--an exercise in health education.

1979 • 71 citations

The annual risk of melanoma progression. Implications for the concept of cure

1992 • 71 citations

Cutaneous malignant melanoma (arizona cancer center experience). I. Natural history and prognostic factors influencing survival in patients with stage i disease

1988 • 65 citations

Primary melanoma of the skin: Recognition and management

1980 • 64 citations

Conservative surgical management of superficially invasive cutaneous melanoma

1984 • 63 citations

Specific Active Immunotherapy for Melanoma

1979 • 58 citations

Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanoma

1981 • 58 citations

Surface microscopy of naevi and melanomas—clues to melanoma

1994 • 55 citations

Malignant melanoma. Changing trends in factors influencing metastasis-free survival from 1964 to 1982

1990 • 52 citations

Cutaneous lymphoscintigraphy in malignant melanoma

1983 • 51 citations

Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.

1994 • 46 citations

Pathologic prognostic factors for cutaneous malignant melanoma: The western canada melanoma study

1989 • 43 citations

Immunological Studies with Human Neoplasms1

2015 • 42 citations

Influence of level and depth on recurrence rate in thin melanomas

1993 • 41 citations

Prognostic index for clinical Stage I cutaneous malignant melanoma.

1983 • 39 citations

Biopsy and Prognosis for Cutaneous Malignant Melanomas in Clinical Stage I

1980 • 39 citations

Preoperative cutaneous lymphoscintigraphy in malignant melanoma

1989 • 34 citations

Early Death from Clinical Stage I Melanoma

1983 • 32 citations

Cutaneous malignant melanoma in Scotland

1982 • 31 citations

Lymphoscintigraphy in patients with malignant melanoma: A quantitative and qualitative evaluation of its usefulness

1984 • 28 citations

Immunotherapy with Sensitized Lymphocytes

1992 • 25 citations

Narrowing resection margins for patients with low-risk melanoma

1988 • 23 citations

Histological type and biological behavior of primary cutaneous malignant melanoma

1983 • 22 citations

Clinical features of superficial spreading melanomas with zones of regression

1984 • 21 citations

Diagnostic problems of second primary malignancies detected by fine-needle aspiration cytology

1993 • 20 citations

Aspiration biopsy--a tool in surgical pathology.

1988 • 19 citations

Scintigraphy of lymphatic vessels in malignant melanoma of the skin before operation (en bloc excision)

1985 • 11 citations

Optimal Resection Margin for Cutaneous Malignant Melanoma

1983 • 9 citations

The in vivo immunomodulatory effects of recombinant interferon gamma plus recombinant tumor necrosis factor-alfa.

1991 • 6 citations